Effects of magnesium sulphate regimens in severe preeclampsia
Comparison of Different Regimens of Magnesium Sulphate in Patients With Severe Preeclampsia in Ain Shams University Maternity Hospital (Retrospective Cohort)
This study looks at how different treatments with magnesium sulphate can help prevent seizures in pregnant women with severe preeclampsia.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 400 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | Ain Shams Maternity Hospital Academic / other |
| Locations | 1 site (Cairo) |
| Trial ID | NCT06791668 on ClinicalTrials.gov |
What this trial studies
This observational study aims to investigate the effects of different regimens of magnesium sulphate used to prevent seizures in pregnant women diagnosed with severe preeclampsia. Researchers will conduct a retrospective review of hospital records from Ain Shams University Maternity Hospital over the past five years to collect data on patient demographics, treatment regimens, and outcomes. The study will focus on the occurrence of eclamptic fits and any complications associated with the various magnesium sulphate regimens administered. By analyzing this data, the study seeks to identify the most effective treatment protocols for managing severe preeclampsia.
Who should consider this trial
Good fit: Ideal candidates for this study are pregnant women diagnosed with severe preeclampsia who have received magnesium sulphate as part of their treatment.
Not a fit: Patients with incomplete medical records regarding magnesium sulphate regimens will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment protocols for preventing seizures in pregnant women with severe preeclampsia.
How similar studies have performed: Other studies have explored magnesium sulphate regimens in preeclampsia, indicating potential for effective seizure prevention, but this specific approach is observational and may provide novel insights.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * All hospital records of patients diagnosed as preeclampsia with severe features planned to receive magnesium sulphate. Exclusion Criteria: * Records with missing data about the regimen of magnesium sulphate used
Where this trial is running
Cairo
- Ain Shams University Maternity Hospital — Cairo, Egypt (Recruiting)
Study contacts
- Study coordinator: Rania HM Ahmed, MD
- Email: raneyah@med.asu.edu.eg
- Phone: 20201200522444
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.